Expanded Access Program for Revumenib
NCT05918913
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Relapsed/Refractory Acute Leukemia
Interventions
DRUG:
Revumenib
Sponsor
Syndax Pharmaceuticals